Trending...
- Governor Newsom honors fallen California Highway Patrol Officer Miguel Cano
- Governor Newsom marks historic expansion of California's Film and Television Tax Credit Program, announces 16 new projects to film in the Golden State
- California: Governor Newsom announces appointments 7.2.25
MILPITAS, Calif. , June 18, 2025 ~ Galaxy Therapeutics, a leading medical device company specializing in the treatment of brain aneurysms, has announced the appointment of Dr. Michael Alexander as their new Chief Medical Officer. With over two decades of experience in neurosurgery and clinical research, Dr. Alexander brings a wealth of knowledge and expertise to the company.
In his new role, Dr. Alexander will provide global medical leadership for Galaxy's clinical development programs, including the ongoing Saccular Endovascular Aneurysm Lattice (SEAL™) IT IDE trial and future studies focused on treating complex brain aneurysms with the SEAL device. This newly created position highlights Galaxy's commitment to advancing their innovative technology and bringing it to patients worldwide.
Dr. Alexander is a highly distinguished specialist in the field of neurosurgery, with dual training in cerebrovascular surgery and neurointerventional procedures. He has held various leadership positions at prestigious institutions such as Cedars-Sinai Medical Center in Los Angeles, where he currently serves as Professor and Vice Chair of Neurosurgery, Co-Director of the Comprehensive Stroke Center, Director of the Neurovascular Center, and Staff Physician IV (Neurosurgery). He also served as Team Neurosurgeon for the Los Angeles Rams during their 2016-2017 season.
More on The Californer
Prior to joining Cedars-Sinai, Dr. Alexander spent seven years as an Associate Professor at Duke University Medical Center and completed a fellowship at UCLA Medical Center. Despite his new role at Galaxy Therapeutics, he will continue to serve in his current academic and clinical positions.
Dr. Sam Zaidat, President and CEO of Galaxy Therapeutics, expressed his excitement about having Dr. Alexander join their executive team. He praised Dr. Alexander's extensive experience in clinical trials and his stellar reputation within the neurointerventional community.
"Dr. Alexander's unmatched clinical trial experience, scientific rigor, and stellar reputation in the neurointerventional community make him an ideal Chief Medical Officer," said Dr. Zaidat. "As such, we are honored to welcome him to the executive team and are confident that he will be instrumental in helping us bring our technology to patients worldwide."
Dr. Zaidat also mentioned that Galaxy Therapeutics will continue to expand its clinical and scientific leadership team as they work towards advancing their innovative SEAL device, designed to address the most challenging aneurysm anatomies.
More on The Californer
Throughout his career, Dr. Alexander has participated in over 45 clinical trials and has been continuously funded by the National Institutes of Health (NIH) for the past 18 years. He is a Past President of the Society of NeuroInterventional Surgery (SNIS), co-author of two textbooks, and has published over 160 peer-reviewed articles in the field of neurovascular disease.
Dr. Alexander received his medical degree from Georgetown University School of Medicine and completed fellowships in Neurovascular and Skull Base Surgery at Barrow Neurological Institute and NeuroIntervention at David Geffen School of Medicine at UCLA.
With Dr. Alexander's expertise and leadership, Galaxy Therapeutics is poised to make significant strides in their mission to provide innovative treatments for brain aneurysms. As they continue to grow, they remain committed to expanding their team with top talent in order to bring their technology to patients around the world.
In his new role, Dr. Alexander will provide global medical leadership for Galaxy's clinical development programs, including the ongoing Saccular Endovascular Aneurysm Lattice (SEAL™) IT IDE trial and future studies focused on treating complex brain aneurysms with the SEAL device. This newly created position highlights Galaxy's commitment to advancing their innovative technology and bringing it to patients worldwide.
Dr. Alexander is a highly distinguished specialist in the field of neurosurgery, with dual training in cerebrovascular surgery and neurointerventional procedures. He has held various leadership positions at prestigious institutions such as Cedars-Sinai Medical Center in Los Angeles, where he currently serves as Professor and Vice Chair of Neurosurgery, Co-Director of the Comprehensive Stroke Center, Director of the Neurovascular Center, and Staff Physician IV (Neurosurgery). He also served as Team Neurosurgeon for the Los Angeles Rams during their 2016-2017 season.
More on The Californer
- Utah Metal Fabricator Titan Forge Builds Momentum with Custom Steel Projects and Spiral Staircases
- Jason Koch: Pioneering the Future of Real Estate Development in New Jersey
- Amid Trump's assault on public lands, California conserves over one million acres of land and coastal waters in just one year
- California: Governor Newsom announces appointments 7.7.25
- City of Long Beach to Upgrade Its Internet Infrastructure to Enhance City Network Reliability and Performance
Prior to joining Cedars-Sinai, Dr. Alexander spent seven years as an Associate Professor at Duke University Medical Center and completed a fellowship at UCLA Medical Center. Despite his new role at Galaxy Therapeutics, he will continue to serve in his current academic and clinical positions.
Dr. Sam Zaidat, President and CEO of Galaxy Therapeutics, expressed his excitement about having Dr. Alexander join their executive team. He praised Dr. Alexander's extensive experience in clinical trials and his stellar reputation within the neurointerventional community.
"Dr. Alexander's unmatched clinical trial experience, scientific rigor, and stellar reputation in the neurointerventional community make him an ideal Chief Medical Officer," said Dr. Zaidat. "As such, we are honored to welcome him to the executive team and are confident that he will be instrumental in helping us bring our technology to patients worldwide."
Dr. Zaidat also mentioned that Galaxy Therapeutics will continue to expand its clinical and scientific leadership team as they work towards advancing their innovative SEAL device, designed to address the most challenging aneurysm anatomies.
More on The Californer
- Groflex Named One of the Top 100 Manufacturing Startups in San Francisco by F6S
- BofA Directs Additional $1 Million to Los Angeles Nonprofits for Evolving Fire Recovery Needs
- Introducing LK Blue: The Cool-Girl Denim Brand That's Redefining LA Style Launches E-Commerce
- THINKWARE Announces Prime Day Deals on Best-Selling Dash Cams
- Zeta Sky Strengthens Cybersecurity Support for Ontario Businesses Facing Rising Identity & Complian
Throughout his career, Dr. Alexander has participated in over 45 clinical trials and has been continuously funded by the National Institutes of Health (NIH) for the past 18 years. He is a Past President of the Society of NeuroInterventional Surgery (SNIS), co-author of two textbooks, and has published over 160 peer-reviewed articles in the field of neurovascular disease.
Dr. Alexander received his medical degree from Georgetown University School of Medicine and completed fellowships in Neurovascular and Skull Base Surgery at Barrow Neurological Institute and NeuroIntervention at David Geffen School of Medicine at UCLA.
With Dr. Alexander's expertise and leadership, Galaxy Therapeutics is poised to make significant strides in their mission to provide innovative treatments for brain aneurysms. As they continue to grow, they remain committed to expanding their team with top talent in order to bring their technology to patients around the world.
Filed Under: Business
0 Comments
Latest on The Californer
- California: TOMORROW: Governor Newsom to join federal, state, and local leaders to recognize six-month anniversary of Los Angeles firestorms
- Skool Alternatives Reddit: Skool vs Circle vs Whop - Did you join one yet?
- Southern Soul Artist Moe Z Releases New Single 'Set It Out' Distributed by Morris Day Entertainment
- SacraPod Suites Unveils AI-Powered 'Work + Rest' Smart Hospitality Model for Retrofitting Underused Motels Across the U.S
- Green Jacket Gateway" System: Your Definitive Path to Golfing Greatness
- From Real Estate to Reel Power: H.L Woods Carves His Legacy as a Cutting-Edge Visionary Filmmaker
- Luxury Auto Detailing Brings High-End Mobile Car Care to Cherry Valley and Surrounding Areas
- Transgender Visual Artist Debuts New Work
- Stay Cool All Day With BGMgirl Drawstring Half Wigs
- California: Governor Newsom proclaims Independence Day 2025
- Gundam GQuuuuuuX Takes Center Stage at Anime Expo 2025
- John Duffy Competes in Mr Muscle Beach
- New Release: 'The Invisible Alternative' Unveiled by Atrisk Corporation, Resilient
- Thorn & Bloom Magazine Unveils Groundbreaking Second Edition: "Breaking the Cycle"
- Cheap O SMS Launches Groundbreaking Free SMS API Service
- California: Governor Newsom signs legislation 7.3.25
- Fireworks, fun, and safety: California preps for the holiday weekend
- BillBoards Inc. Hits the Road with God Bless America Tour and Reality Series Now Streaming on Tubi TV
- Legacy vs. Legacy Gala: Celebrating the Past, Powering the Future of the L.A. Watts Summer Games
- Orion Retreats: Pioneering the Future of Conscious Leadership and Luxury Wellness Tourism